Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Oct. 2, 2014, 52 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $181.44 to $2,011,680.00.

Highlighted Stocks Traded by Insiders:

Owens & Minor (OMI) - FREE Research Report

Smith Craig R, who is Executive Chairman at Owens & Minor, sold 33,000 shares at $32.51 on Oct. 2, 2014. Following this transaction, the Executive Chairman owned 205,712 shares meaning that the stake was reduced by 13.82% with the 33,000-share transaction.

The shares most recently traded at $32.62, up $0.11, or 0.34% since the insider transaction. Historical insider transactions for Owens & Minor go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 33,000
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 66,000
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 68,545

The average volume for Owens & Minor has been 455,700 shares per day over the past 30 days. Owens & Minor has a market cap of $2.0 billion and is part of the services sector and wholesale industry. Shares are down 11.21% year-to-date as of the close of trading on Thursday.

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare logistics company. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices. The stock currently has a dividend yield of 2.9%. The company has a P/E ratio of 21.4. Currently, there are no analysts who rate Owens & Minor a buy, 2 analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OMI - FREE

TheStreet Quant Ratings

rates Owens & Minor as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Owens & Minor Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

GameStop (GME) - FREE Research Report

Zilavy Lawrence S, who is Director at GameStop, sold 3,500 shares at $40.96 on Oct. 2, 2014. Following this transaction, the Director owned 25,340 shares meaning that the stake was reduced by 12.14% with the 3,500-share transaction.

The shares most recently traded at $40.86, down $0.10, or 0.25% since the insider transaction. Historical insider transactions for GameStop go as follows:

  • 4-Week # shares sold: 181,800
  • 12-Week # shares sold: 183,900
  • 24-Week # shares sold: 187,400

The average volume for GameStop has been 2.5 million shares per day over the past 30 days. GameStop has a market cap of $4.5 billion and is part of the services sector and retail industry. Shares are down 17.01% year-to-date as of the close of trading on Thursday.

GameStop Corp. operates as a multichannel video game, consumer electronics, and wireless services retailer. The stock currently has a dividend yield of 3.27%. The company has a P/E ratio of 12.5. Currently, there are 11 analysts who rate GameStop a buy, 2 analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GME - FREE

TheStreet Quant Ratings

rates GameStop as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, reasonable valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

GameStop Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Splunk (SPLK) - FREE Research Report

Neustaetter Thomas M, who is Director at Splunk, sold 6,500 shares at $54.81 on Oct. 2, 2014. Following this transaction, the Director owned 42,064 shares meaning that the stake was reduced by 13.38% with the 6,500-share transaction.

The shares most recently traded at $59.27, up $4.46, or 7.53% since the insider transaction. Historical insider transactions for Splunk go as follows:

  • 4-Week # shares sold: 71,093
  • 12-Week # shares sold: 76,093
  • 24-Week # shares sold: 169,680

The average volume for Splunk has been 2.8 million shares per day over the past 30 days. Splunk has a market cap of $6.4 billion and is part of the technology sector and computer software & services industry. Shares are down 19.48% year-to-date as of the close of trading on Thursday.

Splunk, Inc. provides software solutions that provide real-time operational intelligence in the United States and internationally. Currently, there are 13 analysts who rate Splunk a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPLK - FREE

TheStreet Quant Ratings

rates Splunk as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Splunk Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null